Mgl2 Activators
Mgl2 Activators are a diverse group of chemical compounds that enhance the functional activity of Mgl2, a lectin known for its carbohydrate binding ability, primarily expressed on the external side of the plasma membrane in various tissues such as the ductus deferens, epididymis, ileum, prostate gland, and testis. The activators like Forskolin, Genistein, and Epigallocatechin gallate (EGCG) function by modulating different signaling pathways which indirectly bolster Mgl2's carbohydrate recognition and binding efficiency. Forskolin, by increasing cAMP levels, activates PKA, leading to potential changes in the phosphorylation state of proteins associated with the plasma membrane, thus facilitating Mgl2's binding activity. Genistein, by inhibiting tyrosine kinase, reduces competitive signaling, potentially improving the localization and function of Mgl2 in carbohydrate recognition. EGCG, with its kinase inhibition properties, could similarly affect membrane dynamics and protein interactions, thus enhancing Mgl2's efficiency.
The role of lipid and calcium signaling in modulating Mgl2's activity is underscored by compounds like Sphingosine-1-phosphate, Thapsigargin, and A23187. Sphingosine-1-phosphate, by influencing lipid signaling, may optimize the membrane environment for Mgl2's function. Thapsigargin and A23187, through their roles in elevating intracellular calcium levels, activate calcium-dependent signaling pathways, which could enhance Mgl2's carbohydrate binding activity. Moreover, inhibitors like LY294002, Wortmannin (PI3K inhibitors), SB203580 (p38 MAPK inhibitor), U0126 (MEK1/2 inhibitor), and Staurosporine (broad-spectrum protein kinase inhibitor) play crucial roles in indirectly supporting Mgl2 activity. These inhibitors modify cellular signaling dynamics and membrane protein interactions, leading to a potential increase in Mgl2's functional activity in carbohydrate recognition, thereby emphasizing the intricate network of intracellular pathways and membrane dynamics that regulate Mgl2's role in carbohydrate binding.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Acts as a tyrosine kinase inhibitor, reducing competitive signaling and potentially enhancing Mgl2's carbohydrate binding activity by influencing lectin membrane localization and function. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
A PKC activator that indirectly enhances Mgl2's carbohydrate binding activity by influencing phosphorylation of membrane proteins, potentially altering the membrane environment to facilitate Mgl2 functioning. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Influences lipid signaling pathways, which can indirectly enhance Mgl2 activity by modulating membrane fluidity and protein localization, optimizing Mgl2's function in carbohydrate binding. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Increases intracellular calcium levels, indirectly augmenting Mgl2's carbohydrate binding activity through the activation of calcium-dependent signaling pathways, influencing membrane localization and function of Mgl2. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that indirectly supports Mgl2 activity by altering PI3K/Akt signaling pathways, potentially enhancing Mgl2's carbohydrate recognition efficiency through changes in membrane protein distribution and phosphorylation states. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor, indirectly aids Mgl2 activity by modifying membrane dynamics and protein interactions, potentially improving Mgl2's function in binding specific carbohydrates. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that can indirectly promote Mgl2 activity. Inhibition of p38 MAPK might shift cellular signaling dynamics, enhancing the carbohydrate binding activity of Mgl2 through altered membrane protein interactions. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
A MEK1/2 inhibitor that indirectly enhances Mgl2 activity by influencing the MAPK/ERK pathway. This inhibition can modify membrane-associated processes, potentially aiding Mgl2's role in carbohydrate binding. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Acts as a calcium ionophore, indirectly enhancing Mgl2 activity by increasing intracellular calcium levels. Elevated calcium activates several signaling pathways, potentially influencing Mgl2's membrane-associated activity in carbohydrate binding. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Known for inhibiting various kinases, EGCG can indirectly augment Mgl2 activity. By inhibiting specific kinases, it may influence the membrane environment and protein interactions, facilitating Mgl2's role in carbohydrate binding. | ||||||